p52-/p36-/sap1-GAP vaccine (Seattle Biomedical Research Institute)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug Namep52-/p36-/sap1-GAP vaccine (Seattle Biomedical Research Institute)
Drug Alias NameGAP3KO vaccine (malaria)
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Live attenuated vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMalaria
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCenter For Infectious Disease Research
China Registration ClassN/A

Develop Information

Active CompaniesCenter For Infectious Disease Research
Inactive CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)
Active IndicationsMalaria
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A